COMMUNIQUÉS West-GlobeNewswire

Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
21/05/2024
Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech [...]
BioCardia Announces Reverse Stock Split
21/05/2024
SUNNYVALE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that [...]
Atrion Corporation Declares Quarterly Cash Dividend
21/05/2024
ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. [...]
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
21/05/2024
Updated Nanobiotix corporate strategy designed to enable long-term growth through execution of the global NBTXR3 collaboration and platforms beyond NBTXR3 Alignment of intent to transfer the sponsorship of the ongoing [...]
Nanobiotix annonce des avancees de la collaboration globale de developpement autour de NBTXR3 refletant son pipeline robuste et son approche de croissance sur le long terme
21/05/2024
Mise à jour de la stratégie d'entreprise de Nanobiotix dans la perspective d’une croissance à long terme reposant sur la mise en œuvre de la collaboration globale portant sur NBTXR3 et des plateformes autres que NBTXR3 [...]
Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
21/05/2024
Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study to be released in June 2024 Enrollment into the Phase 3 portion of IMPAHCT continues at more [...]
Relay Therapeutics to Participate in Upcoming Investor Conferences
21/05/2024
CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and [...]
LifeStance Health Group Announces Launch of Secondary Public Offering
21/05/2024
SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
Trinity Biotech plc to Announce Q1 2024 Financial Results
21/05/2024
Conference Call Scheduled for Thursday, May 23, 2024 at 8:30 AM ET. DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused [...]
Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
21/05/2024
SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
21/05/2024
Met primary study endpoints: good safety profile and reduction in central subfield thickness (CST) First oral therapy to demonstrate reduction in macular edema; supports potential for early disease intervention Virtual [...]
Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
21/05/2024
Cash and cash equivalents at €11.0 million, short-term 2 deposits at €0.1million, and long-term deposit at €19.1 million 3 as of March 31, 2024, compared to €26.9 million, €0.01 million and €9.0 million as of December [...]
Inventiva publie ses informations financières du 1 ͤ ͬ trimestre 2024¹ et fait un point sur ses activités
21/05/2024
Au 31 mars 2024, trésorerie et équivalents de trésorerie à 11,0 millions d’euros, dépôt court terme 2 à 0,1 million d’euros et dépôt long terme à 19,1 millions d'euros 3 , contre 26,9 millions d’euros, 0,01 million d’ [...]
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
21/05/2024
JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the [...]
Smart for Life to Attend the 2024 NASC Annual Conference
21/05/2024
Management to Explore Strategic Partnerships and Acquisition Opportunities at Premier Animal Health Event MIAMI, May 21, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), [...]
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
21/05/2024
Nature Medicine published Up-LIFT pivotal trial results Company will discuss pivotal trial results during webcast this week with company leaders and study principal investigators and participants EINDHOVEN, the [...]
Legend Senior Living Earns Great Place to Work® Certification for Sixth Time
21/05/2024
WICHITA, Kan., May 21, 2024 (GLOBE NEWSWIRE) -- Great Place to Work Institute has honored Legend Senior Living® with certification as a Great Place to Work for the sixth time. The certification process considered more [...]
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
21/05/2024
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were [...]
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
21/05/2024
Westport, CT, May 21, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]

Pages